CD274 and neoplasm: Flow cytometry analysis of tumours treated with a combination of CD3xCEA and anti-PD-L1 revealed a lower proportion of anergic T-cells (expressing PD-1, TIM-3, and LAG-3) compared to monotherapy, further evidencing that this combination is capable of improving T-cell functioning [15].